Evidence map›Paper›PMID 28475159›Full record

Trial reportNutrients2017

Acute Vitamin D₃ Supplementation in Severe Obesity: Evaluation of Multimeric Adiponectin.

Stefania Mai, Gillian E Walker, Roberta Vietti, Stefania Cattaldo, Chiara Mele, Lorenzo Priano, Alessandro Mauro, Gianni Bona, Gianluca Aimaretti, Massimo Scacchi and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Characterization and Treatment of Inflammation and Insulin Resistance in Obese Adipose Tissue.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Review
  14. Review
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stefania MaiLaboratory of Metabolic Research, Ospedale S. Giuseppe, I.R.C.S.S. Istituto Auxologico Italiano, 28921 Piancavallo-Verbania, Italy. s.mai@auxologico.it.
Gillian E WalkerLaboratory of Paediatrics, Department of Health Sciences, Università del Piemonte Orientale, 28100 Novara, Italy. gillian.walker@med.uniupo.it.
Roberta ViettiLaboratory of Metabolic Research, Ospedale S. Giuseppe, I.R.C.S.S. Istituto Auxologico Italiano, 28921 Piancavallo-Verbania, Italy. r.vietti@auxologico.it.
Stefania CattaldoLaboratory of Clinical Neurobiology, I.R.C.C.S. Istituto Auxologico Italiano, Ospedale S. Giuseppe, 28921 Piancavallo-Verbania, Italy. s.cattaldo@auxologico.it.
Chiara MeleDivision of General Medicine, I.R.C.C.S. Istituto Auxologico Italiano, Ospedale S. Giuseppe, 28921 Piancavallo-Verbania, Italy. chiara.mele1989@gmail.com.
Lorenzo PrianoLaboratory of Clinical Neurobiology, I.R.C.C.S. Istituto Auxologico Italiano, Ospedale S. Giuseppe, 28921 Piancavallo-Verbania, Italy. lorenzo.priano@unito.it.
Alessandro MauroLaboratory of Clinical Neurobiology, I.R.C.C.S. Istituto Auxologico Italiano, Ospedale S. Giuseppe, 28921 Piancavallo-Verbania, Italy. alessandro.mauro@unito.it.
Gianni BonaLaboratory of Paediatrics, Department of Health Sciences, Università del Piemonte Orientale, 28100 Novara, Italy. gianni.bona@med.uniupo.it.
Gianluca AimarettiEndocrinology, Department of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy. gianluca.aimaretti@med.uniupo.it.
Massimo ScacchiDivision of General Medicine, I.R.C.C.S. Istituto Auxologico Italiano, Ospedale S. Giuseppe, 28921 Piancavallo-Verbania, Italy. massimo.scacchi@unimi.it.
Paolo MarzulloDivision of General Medicine, I.R.C.C.S. Istituto Auxologico Italiano, Ospedale S. Giuseppe, 28921 Piancavallo-Verbania, Italy. paolo.marzullo@med.uniupo.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity predisposes to vitamin D deficiency (VDD) and glucose abnormalities. It is currently debated if vitamin D administration may improve glucose homeostasis by interacting with modulators of insulin sensitivity, such as adiponectin and its oligomers. In a 4-week inpatient study on a metabolic rehabilitation program, consisting of individualized caloric restriction and aerobic physical exercise in obese subjects with VDD, we assessed the acute effects of 600,000 IU cholecalciferol given per os VD group, 12 subjects; body mass index (BMI) 42.7 ± 1.3 kg/m²) or placebo per os (PL group, 12 subjects, BMI 39.8 ± 0.9 kg/m²) on high (HWM-A), medium (MMW-A), and low molecular weight adiponectin (LMW-A), as quantified by western immunoblot (WIB) and ELISA. During the 4-week study, dieting promoted a similar magnitude of weight loss in VD and PL groups. Compared to the PL group, cholecalciferol administration increased 25(OH)Vit D levels (

Indexed as

AdiponectinAdultBody Mass IndexCaloric RestrictionCholecalciferolExerciseFemaleHumansInsulin ResistanceLeptinMaleMolecular WeightObesity, MorbidSingle-Blind MethodVitamin D DeficiencyWeight LossAdiponectinCholecalciferolLeptinmultimeric adiponectinobesityvitamin Dweight loss

Identifiers

PMID28475159
PMCPMC5452189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.